TSX open
Loading markets…

Advertisement

Stocks/TSX/BCT

Briacell Therapeutics Corp (BCT : TSX)

Common Stock

$4.87

CAD

+0.08 (1.67%)

Last updated: 2026-10-26

Follow BCT

BCT

Briacell Therapeutics Corp

Source:WealthAwesomeWealthAwesome
↓ $0.11 (-2.21%)
30 day period
$4.79$5.45$6.10Sep 14Oct 5Oct 26

Performance

1 Day

+1.67%

1 Week

+1.25%

1 Month

-19.37%

YTD

-50.41%

Key Statistics

Market Cap

$41.67M

52W High

$18.48

52W Low

$3.68

P/E Ratio

-

50 Day MA

$5.30

200 Day MA

$5.43

Beta

1.51

Dividend Yield

-

Advertisement

Technical Indicators

Price vs 50-Day SMA

↓Below 50 SMA

Price vs 200-Day SMA

↓Below 200 SMA

Recent Price History

DateOpenHighLowCloseAdj CloseVolume
10/26/2026$5.02$5.03$4.86$4.87$4.874,082
10/23/2026$4.78$4.79$4.72$4.79$4.791,187
10/22/2026$5.11$5.11$4.77$4.84$4.844,398
10/21/2026$4.86$5.08$4.86$5.08$5.081,504
10/20/2026$4.78$5.05$4.77$4.86$4.864,000
10/19/2026$4.86$4.87$4.81$4.81$4.811,926
10/16/2026$5.41$5.41$4.80$4.88$4.8815,457
10/15/2026$5.26$5.36$5.26$5.36$5.36891
10/14/2026$5.38$5.50$5.25$5.25$5.252,967
10/13/2026$5.56$5.56$5.30$5.31$5.314,304

Analyst Price Targets

Based on analyst covering BCT · as of Sep 17, 2026

📈

Wall Street analysts forecast BCT stock price to rise 310.7% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$20.00

+310.7% Upside

Current Price

C$4.87

Last close

Compare analyst targets →

Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on BCT's historical volatility

HistoricalForecast68%95%
C$1.98C$4.04C$6.09C$8.15C$10.21C$12.26TodayJun 17Aug 21Oct 26Dec 8Jan 21Mar 5

30-Day Vol

73.8%

Annualized

90-Day Vol

71.6%

Annualized

Trend (90d)

+3.5%

Annualized drift

90d Mean

C$4.93

Expected price

HorizonExpected68% Range (1σ)
30 trading daysC$4.89C$3.79 – C$6.31
60 trading daysC$4.91C$3.43 – C$7.04
90 trading daysC$4.93C$3.17 – C$7.66

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

About Briacell Therapeutics Corp

BriaCell Therapeutics Corp., a pre-clinical stage immuno-oncology company, engages in developing targeted immunotherapies to transform cancer care. Its lead candidate is Bria-IMT, a targeted immunotherapy program against end-stage breast cancer that is in Phase 3 clinical trials. The company develops Bria-OTS, a personalized off-the-shelf immunotherapy; and a soluble CD80 protein therapeutic that acts as a stimulator of the immune system and an immune checkpoint inhibitor. It has a license agreement with the University of Maryland, Baltimore County to develop and commercialize soluble CD80 as a biologic agent for the treatment of cancer. BriaCell Therapeutics Corp., has a collaboration with MSK Accelerator to accelerate theclinical development of Bria-OTS+ for multiple cancer indications including metastatic breast cancer, prostate cancer, and other cancers. The company is headquartered in West Vancouver, Canada.

Financials

Revenue (TTM)
$0
EBITDA
$-31.92M
Profit Margin
0.00%
ROE (TTM)
-175.26%
EPS (Diluted)
-1.27
Book Value
4.66

Classification

Sector
Health Care
Industry
Biotechnology
Group
Pharmaceuticals, Biotechnology & Life Sciences

🔄 Recent Splits

1-for-10

Aug 25, 2025

Reverse

1-for-15

Jan 29, 2025

Reverse

1009-for-1000

Sep 5, 2023

Split

7 stocks to buy and hold forever

Blue-chip dividend stocks for long-term wealth building.

Get the FREE Report

Advertisement

Common Questions About BCT

Market movers

Recent TSX movers

Top 1-day gainers — updated from our Canadian movers feed.

All movers →
TickerNamePrice1D
HLFHigh Liner Foods Incorporated$26.76+77.45%
HBPHelix BioPharma Corp.$0.99+20.73%
BRYBri-Chem Corp.$0.27+12.50%
BCHTBirchtech Corp.$1.75+10.06%
AVNTAvant Brands Inc$0.55+10.00%
CWLCaldwell Partners International Inc$1.17+9.35%
GRCGold Springs Resource Corp$0.06+9.09%
FFMFireFly Metals Ltd.$1.30+8.33%

BCT.TO news timeline

15 articles covering BCT.TO, most recent first

Latest

Why Briacell Therapeutics Corp stock is sliding today

•Stocks

Advertisement